➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Dow
Moodys
Baxter
Mallinckrodt

Last Updated: November 30, 2020

DrugPatentWatch Database Preview

Litigation for ONGLYZA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Court Litigation for ONGLYZA

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,395,767 AstraZeneca AB v. Mylan Pharmaceuticals Inc.   Start Trial 2014-06-03 35:145 Patent Infringement District Court, N.D. West Virginia None   Start Trial
6,395,767   Start Trial   Start Trial 2014-05-23 2017-02-01 35:271 Patent Infringement District Court, D. Delaware Defendant   Start Trial
6,395,767   Start Trial   Start Trial 2014-05-23 35:271 Patent Infringement District Court, D. Delaware Defendant   Start Trial
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for ONGLYZA

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
RE44,186 Mylan Pharmaceuticals Inc.   Start Trial 2015-06-04 06-04-2015 AstraZeneca AB Inter partes review   Start Trial 05-02-2016 Jeffrey Robl   Start Trial
RE44,186 Wockhardt Bio AG   Start Trial 2016-05-11 05-11-2016 AstraZeneca AB Inter partes review   Start Trial 08-23-2016 Jeffrey Robl   Start Trial
RE44,186 Amneal Pharmaceuticals LLC   Start Trial 2016-06-01 06-03-2016 AstraZeneca AB Inter partes review   Start Trial 11-22-2016 Jeffrey Robl   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Merck
Boehringer Ingelheim
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.